Multicentric Study of Adherence to Antiseizure Medications Among Adults with Epilepsy Attended in Neurology Departments in Burkina Faso

Overview

Journal Epilepsia Open

Date 2024 Nov 11

PMID 39526846

Authors

Alfred Anselme Dabilgou

Alassane Drave

Julie Marie Adeline Wendlamita Kyelem

Adama Kabore

Christian Napon

Athanase Millogo

Kapoune Karfo

Jean Kabore

Affiliations

Soon will be listed here.

Abstract

Objective: To study the adherence of antiseizures medication in neurology in the city of Ouagadougou.

Patients And Methods: We conducted a multicentric cross-sectional study on adherence to antiseizure medications among adult patients with epilepsy followed by outpatient neurology consultations. The patients were recruited from November 22, 2021 to February 22, 2022 in four departments of neurology. Adherence to antiseizure medications (ASM) was measured using the Morisky Medication Adhesion Scale (MMAS). Logistic regression analysis was used to investigate factors associated with adherence.

Results: One hundred and seven patients with a mean age of 38.92 ± 16.06 years were included in the study. Most of the patients were men (52.34%). Twenty-eight patients complied well with ASM (26.17%). The main causes of nonadherence to treatment were forgetfulness and lack of financial means. Factors associated with nonadherence were rural residence (p = 0.023), celibacy or divorce (p = 0.002), low level of education (p = 0.028), perception of stigma (p = 0.026), duration of epilepsy <5 years (p = 0.009).

Conclusions: Adherence to ASM is low in Burkina Faso. The main causes of nonadherence were forgetting and insufficiency of financial resources. Rural residence, celibacy, or divorce, low level of education, perception of stigmatization, and short duration of epilepsy were associated with non-adherence.

Plain Language Summary: Studies on adherence to antiseizure medications are rare in Africa while patients do not have access to adequate treatment. The aim of our study was to evaluate the adherence to antiseizure medications among patients with epilepsy followed by the neurology departments in the city of Ouagadougou. Forgetfulness and financial insufficiency were the main causes of treatment interruption. Our study showed that most of the patients were non adherent. Several factors such as place of residence, level of education, and duration of epilepsy influence the level of compliance.

Citing Articles

Multicentric study of adherence to antiseizure medications among adults with epilepsy attended in neurology departments in Burkina Faso.

Dabilgou A, Drave A, Kyelem J, Kabore A, Napon C, Millogo A Epilepsia Open. 2024; 10(1):168-176.

PMID: 39526846 PMC: 11803283. DOI: 10.1002/epi4.13092.

References

Minwuyelet F, Mulugeta H, Tsegaye D, Lake B, Getie A, Tsegaye B . Quality of life and associated factors among patients with epilepsy at specialized hospitals, Northwest Ethiopia; 2019. PLoS One. 2022; 17(1):e0262814. PMC: 8794165. DOI: 10.1371/journal.pone.0262814. View

Abd Wahab E, Al Omar M, Altabakha M . Adherence to Antiepileptic Drugs among Patients Attending the Neuro Spinal Hospital in the United Arab Emirates. J Pharm Bioallied Sci. 2021; 12(4):499-507. PMC: 7909063. DOI: 10.4103/jpbs.JPBS_367_19. View

Chapman S, Horne R, Chater A, Hukins D, Smithson W . Patients' perspectives on antiepileptic medication: relationships between beliefs about medicines and adherence among patients with epilepsy in UK primary care. Epilepsy Behav. 2013; 31:312-20. DOI: 10.1016/j.yebeh.2013.10.016. View

Henning O, Johannessen Landmark C, Nakken K, Lossius M . Nonadherence to treatment regimens in epilepsy from the patient's perspective and predisposing factors: Differences between intentional and unintentional lack of adherence. Epilepsia. 2019; 60(5):e58-e62. DOI: 10.1111/epi.14734. View

Davis K, Candrilli S, Edin H . Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population. Epilepsia. 2007; 49(3):446-54. DOI: 10.1111/j.1528-1167.2007.01414.x. View

Chesaniuk M, Choi H, Wicks P, Stadler G . Perceived stigma and adherence in epilepsy: evidence for a link and mediating processes. Epilepsy Behav. 2014; 41:227-31. DOI: 10.1016/j.yebeh.2014.10.004. View

Cramer J, Roy A, Burrell A, Fairchild C, Fuldeore M, Ollendorf D . Medication compliance and persistence: terminology and definitions. Value Health. 2008; 11(1):44-7. DOI: 10.1111/j.1524-4733.2007.00213.x. View

Gurumurthy R, Chanda K, Sarma G . An evaluation of factors affecting adherence to antiepileptic drugs in patients with epilepsy: a cross-sectional study. Singapore Med J. 2016; 58(2):98-102. PMC: 5311891. DOI: 10.11622/smedj.2016022. View

Morisky D, Green L, Levine D . Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986; 24(1):67-74. DOI: 10.1097/00005650-198601000-00007. View

10.

Suzuki H, Mikuni N, Ohnishi H, Yokoyama R, Enatsu R, Ochi S . Forgetting to take antiseizure medications is associated with focal to bilateral tonic-clonic seizures, as revealed by a cross-sectional study. PLoS One. 2020; 15(10):e0240082. PMC: 7529199. DOI: 10.1371/journal.pone.0240082. View

11.

Kwan P, Brodie M . Early identification of refractory epilepsy. N Engl J Med. 2000; 342(5):314-9. DOI: 10.1056/NEJM200002033420503. View

12.

Elsayed M, El-Sayed N, Badi S, Ahmed M . Factors affecting adherence to antiepileptic medications among Sudanese individuals with epilepsy: A cross-sectional survey. J Family Med Prim Care. 2019; 8(7):2312-2317. PMC: 6691456. DOI: 10.4103/jfmpc.jfmpc_405_19. View

13.

Kronish I, Ye S . Adherence to cardiovascular medications: lessons learned and future directions. Prog Cardiovasc Dis. 2013; 55(6):590-600. PMC: 3639439. DOI: 10.1016/j.pcad.2013.02.001. View

14.

Mbuba C, Ngugi A, Fegan G, Ibinda F, Muchohi S, Nyundo C . Risk factors associated with the epilepsy treatment gap in Kilifi, Kenya: a cross-sectional study. Lancet Neurol. 2012; 11(8):688-96. PMC: 3404220. DOI: 10.1016/S1474-4422(12)70155-2. View

15.

Liu J, Liu Z, Ding H, Yang X . Adherence to treatment and influencing factors in a sample of Chinese epilepsy patients. Epileptic Disord. 2013; 15(3):289-94. DOI: 10.1684/epd.2013.0588. View

16.

Duron R, Medina M, Nicolas O, Varela F, Ramirez F, Battle S . Adherence and complementary and alternative medicine use among Honduran people with epilepsy. Epilepsy Behav. 2009; 14(4):645-50. DOI: 10.1016/j.yebeh.2009.01.022. View

17.

Farrukh M, Makmor Bakry M, Hatah E, Hui Jan T . Medication adherence status among patients with neurological conditions and its association with quality of life. Saudi Pharm J. 2021; 29(5):427-433. PMC: 8180465. DOI: 10.1016/j.jsps.2021.04.003. View

18.

Singh P, Gupta K, Singh G, Kaushal S . Simultaneous Use of Two Different Tools to Assess Compliance with Antiepileptic Drugs: Experience in A Community-Based Study. J Neurosci Rural Pract. 2020; 11(4):636-639. PMC: 7595799. DOI: 10.1055/s-0040-1715991. View

19.

Bhalla D, Lotfalinezhad E, Amini F, Delbari A, Fadaye-Vatan R, Saii V . Medication Beliefs and Adherence to Antiseizure Medications. Neurol Res Int. 2020; 2020:6718915. PMC: 7604606. DOI: 10.1155/2020/6718915. View

20.

Mbuba C, Ngugi A, Newton C, Carter J . The epilepsy treatment gap in developing countries: a systematic review of the magnitude, causes, and intervention strategies. Epilepsia. 2008; 49(9):1491-503. PMC: 3573323. DOI: 10.1111/j.1528-1167.2008.01693.x. View